What's New
Prescriber Update 47(1) March 2026
We've published the latest issue of Prescriber Update.
This issue contains important safety information about gynaecomastia with medicines, Fournier's gangrene with empagliflozin, zoledronic acid use in elderly patients, and more.
News and Events
| Date | Type | Title |
|---|---|---|
| 5/3/2026 | Publications | Prescriber Update Vol. 47. No. 1 - March 2026 |
| 2/3/2026 | Consultation | Outcome of the consultation on the proposal for the package labelling of topical corticosteroids to state their potency |
| 20/2/2026 | Consultation | Verification Pathway for New Medicine Applications |
| 16/2/2026 | Medicines | Policy Statements - Declaring excipient(s) with known effect in data sheets |
| 26/1/2026 | Monitoring Communication |  Glucagon-like peptide-1 receptor agonists (dulaglutide, liraglutide, semaglutide, tirzepatide) and acute persistent visual loss |
| 15/1/2026 | Notices | Updated Clinical Trial Guidelines |
| 15/1/2026 | Consultation | Outcome of the consultation on the proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Clinical Trials |
| 15/1/2026 | Consultation | Proposed extension of the abbreviated procedure for new medicine applications and section 24(5)(a) notifications |
| 7/1/2026 | Notices | Notice of Medsafe Office Closure Christmas/New Year 2025/2026 |
